Metabolic-associated fatty liver disease (MAFLD), which is often linked to obesity,
encompasses a large spectrum of hepatic lesions, including simple fatty liver …

Simple Summary The global prevalence of metabolic-associated fatty liver disease (MAFLD)
is rising due to urbanization, obesity, poor diet, sedentary lifestyles, and genetic factors. We …

Obesity is characterized by the deposition of excessive body fat, and is caused by energy
imbalance, especially when consuming fat-rich diets. High fat diet (HFD)-associated obesity …

The liver is the central metabolic organ of the body. The plethora of anabolic and catabolic
pathways in the liver is tightly regulated by physiological signaling but may become …

Abstract Purpose of Review Metabolic-associated fatty liver disease (MAFLD) is a condition
of fat accumulation in the liver that occurs in the majority of patients in combination with …

Non-alcoholic fatty liver disease (NAFLD) is considered the most common liver disorder,
affecting around 25% of the population worldwide. It is a complex disease spectrum, closely …

Nonalcoholic fatty liver disease (NAFLD) has become an increasingly common disease in
Western countries and has become the major cause of liver cirrhosis or hepatocellular …

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are
some of the biggest public health challenges due to their spread and increasing incidence …

Non-alcoholic fatty liver disease (NAFLD) is currently the world's most common liver
disease, estimated to affect up to one-fourth of the population. Hallmarked by hepatic …

Non-alcoholic fatty liver disease (NAFLD) is a chronic hepatic disorder affecting up to 25% of
the general population. Several intracellular events leading to NAFLD and progression to …